Stock RXRX RECURSION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector consensus Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:00:00 18/09/2024 BST 		5-day change 1st Jan Change
6.910 USD +2.22% Intraday chart for Recursion Pharmaceuticals, Inc. +9.34% -29.92%
09-03 Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating MT
09-03 Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends MT
Main competitors
Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Analyst Opinion 4m Target Price Revision 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Average Target P. Ecart obj. / dr Nbr of analysts
RECURSION PHARMACEUTICALS, INC. Stock Recursion Pharmaceuticals, Inc.
 10.14 +50.04%7
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 509.82 +5.93%29
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 1,162.19 +1.35%25
ARGENX SE Stock argenx SE
 510.75 +5.99%15
BIONTECH SE Stock BioNTech SE
 104.71 -6.66%18
BEIGENE, LTD. Stock BeiGene, Ltd.
 272.96 +38.20%21
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
 22.54 +13.21%3
GENMAB A/S Stock Genmab A/S
 2,409.94 +35.77%17
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 58.49 +46.89%17
VAXCYTE, INC. Stock Vaxcyte, Inc.
 145.00 +24.20%7
INSMED INCORPORATED Stock Insmed Incorporated
 87.50 +19.44%16
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
 168.72 +37.94%25
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
 194.36 +54.64%19
ZEALAND PHARMA A/S Stock Zealand Pharma A/S
 1,022.29 +11.60%7
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
 82.93 +62.07%19
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
 173.51 +31.59%13
AKESO, INC. Stock Akeso, Inc.
 59.55 -9.39%21
EXELIXIS, INC. Stock Exelixis, Inc.
 27.49 -0.40%21
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
 60.60 -2.15%10
Average 372.82 +22.12% 16
Weighted average by Cap. 605.77 +12.28% 21
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. Sector Recursion Pharmaceuticals, Inc.
  5. Sector consensus
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition